In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and recent reports about the New World screwworm. Dr. Morice also shares insights on building an innovation strategy that delivers meaningful organizational value.

• PAMA reform update (00:40): Dr. Morice discusses the status of the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act and PAMA.
• Tracking the New World screwworm (02:24): Learn about recent cases of the New World screwworm, why this parasitic fly is problematic, and how sterile insects help contain it.
• Developing an innovation strategy that drives value (04:49): Discover lessons from Dr. Morice’s experience developing a strategic approach to innovation that delivers meaningful outcomes and impact.

Resources

• 4 steps to establishing a new approach to innovation

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss “rabbit fever” cases in New York and strategies for responding to industry trends. Later, Dr. Pritt welcomes Mary Jo Williamson, Mayo Clinic Laboratories’ chief administrative officer, to share practical strategies for leading teams through periods of rapid change.

• Strategies for making strategic progress amid disruption (00:29): Discover practical insights from a recent Forbes article by Dr. Morice on identifying healthcare industry disruptors and determining how organizations should respond.
• A rare tick-borne illness (07:21): Learn about suspected cases of the rare tick-borne illness tularemia, also known as "rabbit fever.”
• Leading through change (09:02): Williamson shares lessons from more than three decades of healthcare leadership, offering practical guidance for helping teams navigate change with confidence and purpose.

Resources

• Forbes: Understanding healthcare industry disruptors and what comes next
• Tick-borne disease: An expanding threat
• Five steps to manage change in an outreach laboratory
• Mary Jo Williamson talks resiliency and agility on Fierce Healthcare podcast
• Mary Jo Williamson shares strategic investment insights with Modern Healthcare

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the Protecting Access to Medicare Act (PAMA) and a recent Cyclospora outbreak making headlines. Later, Dr. Pritt welcomes Juliana Perez Botero, M.D., a Mayo Clinic hematologist, to explore innovative testing approaches for bleeding disorders.

• PAMA data collection and reform (01:05): With data collection for PAMA underway, Dr. Morice shares the latest on potential updates to the law.
• Cyclospora outbreak (05:45): Get a microbiologist’s perspective on the recent Cyclospora outbreak and learn practical steps to help reduce your risk of infection.
• The value of laboratory testing for bleeding disorders (08:37): Discover why laboratory testing plays a critical role in the diagnosis and management of patients with bleeding disorders.
• Innovation for bleeding disorder testing (12:56): Learn how genotype assays are enhancing patient care and how advances in nanotechnology and collaborative research are opening new possibilities for the future.

Resources

• Mayo Clinic Classical Hematology Conference
• Bleeding disorders: The right test at the right time
• Cyclospora Stain, Feces (Mayo ID: CYCL)